Rani Therapeutics Holdings Class ARANI
13F holders, Q1 2024 (March 31)37holders
2famous investors
$3.11avg. 13F price*
At the end of Q1 2024, 37 institutions reported holding Rani Therapeutics Holdings Class A (RANI) in their 13F filings. The largest holders were Vanguard Group Inc. ($2.1M), Nan Fung Group Holdings Ltd ($1.5M) and United Services Automobile Association ($1.5M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Rani Therapeutics Holdings Class A
- CUSIP
- 753018100
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $111K |
| Exits | 1 | $3K |
Ownership 37 holders
| Vanguard Group Inc. | 0.00% | Add +2.5% | 685,303 | $2.1M |
| Nan Fung Group Holdings Ltd | 1.42% | No change | 493,584 | $1.5M |
| United Services Automobile Association | 0.04% | No change | 481,300 | $1.5M |
| Alphabet Inc. | 0.06% | No change | 448,492 | $1.4M |
| Takeda Pharmaceutical Co. Ltd. | 0.36% | No change | 338,679 | $1.1M |
| Stifel Financial Corp. | 0.00% | Add +163.5% | 132,434 | $412K |
| Geode Capital Management, LLC | 0.00% | Add +15.2% | 130,906 | $407K |
| Bank of America Corp. | 0.00% | Add +9.0% | 124,505 | $387K |
| Renaissance Technologies | 0.00% | Add +60.9% | 70,300 | $219K |
| BlackRock Inc. | 0.00% | No change | 63,583 | $198K |
| Lasry Marc | 0.17% | No change | 62,887 | $196K |
| King Luther Capital Management Corp. | 0.00% | No change | 56,129 | $175K |
| Bridgeway Capital Management, LLC | 0.00% | No change | 51,500 | $160K |
| Motco | 0.01% | No change | 48,129 | $150K |
| Brown Advisory Inc. | 0.00% | No change | 33,911 | $105K |
| State Street Corp. | 0.00% | No change | 33,742 | $105K |
| Alpha Square Group S LLC | 0.19% | Reduce -43.3% | 33,401 | $104K |
| Northern Trust Corp. | 0.00% | Add +33.8% | 25,988 | $81K |
| HRT Financial LP | 0.00% | New | 22,587 | $70K |
| Lafayette Investments, Inc. | 0.01% | No change | 19,893 | $62K |
| Choreo, LLC | 0.00% | No change | 19,813 | $62K |
| Prime Capital Investment Advisors, LLC | 0.00% | Reduce -16.8% | 13,882 | $43K |
| JPMorgan Chase & Co. | 0.00% | Add +243.1% | 12,686 | $39K |
| Citadel Advisors | 0.00% | New | 10,032 | $31K |
| Activest Wealth Management | 0.01% | No change | 9,800 | $30K |
| Islay Capital Management, LLC | 0.02% | No change | 9,611 | $30K |
| PNC Financial Services Group, Inc. | 0.00% | No change | 9,116 | $28K |
| Allworth Financial LP | 0.00% | No change | 3,119 | $10K |
| UBS Group AG | 0.00% | New | 3,000 | $9K |
| Morgan Stanley | 0.00% | Reduce -52.9% | 2,451 | $8K |
| Simplex Trading, LLC | 0.00% | Reduce -85.1% | 1,364 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -46.3% | 1,239 | $4K |
| Rhumbline Advisers | 0.00% | No change | 312 | $970 |
| Wells Fargo & Company | 0.00% | Add +1.0% | 103 | $320 |
| Barclays PLC | 0.00% | New | 39 | $121 |
| Qube Research & Technologies Ltd | 0.00% | No change | 3 | $9 |
| Royal Bank of Canada | 0.00% | No change | 12 | $0 |
"% of holder's portfolio" is RANI's weight in each manager's 13F, not the share of Rani Therapeutics Holdings Class A the manager owns.